Australasian Psychiatry最新文献_第5页

Revisiting Australian psychiatrists' and psychiatric trainees' knowledge, attitudes and preparedness in responding to adults experiencing domestic violence. 回顾澳大利亚精神科医生和精神科学员在应对遭受家庭暴力的成年人方面的知识、态度和准备。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-26 DOI: 10.1177/10398562261491645

Grace Burrett, Soumitra Das, Kelsey Hegarty, Manjula O'Connor

{"title":"Revisiting Australian psychiatrists' and psychiatric trainees' knowledge, attitudes and preparedness in responding to adults experiencing domestic violence.","authors":"Grace Burrett, Soumitra Das, Kelsey Hegarty, Manjula O'Connor","doi":"10.1177/10398562261491645","DOIUrl":"https://doi.org/10.1177/10398562261491645","url":null,"abstract":"ObjectiveTo examine family violence (FV) training, preparedness, knowledge, and comfort among Australian psychiatrists and psychiatric trainees, and compare findings with a 2016 national survey.MethodsAn anonymous online survey was distributed via email to members of the Royal Australian and New Zealand College of Psychiatrists. Measures included a shortened PREMIS assessing knowledge and preparedness, and an open-ended question on barriers to managing FV. Quantitative data were analysed using descriptive statistics, t-tests, one-way ANOVA, and chi-square tests. Open-ended responses were analysed using conventional content analysis.ResultsOf respondents completing the survey (232), 20.3% had received less than 1 hour of FV training. Preparedness and knowledge remained in the moderate range and were slightly lower than in 2016. Greater FV training was associated with higher preparedness, knowledge, and comfort; more years in practice with higher preparedness and knowledge. Only 24.6% reported routinely enquiring about FV with all new patients, compared with 44.0% in 2016. Common barriers were limited knowledge and skills, uncertainty about referral pathways, time pressures, and inadequate resources.ConclusionsLittle improvement was evident over time. Greater FV-specific training was consistently associated with better outcomes, supporting structured and sustained FV education in psychiatric training and practice.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562261491645"},"PeriodicalIF":1.7,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149057297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Neuropeptide Y levels, social functionality, and cognitive insight in patients with schizophrenia in symptomatic remission: A case-control study. 症状缓解的精神分裂症患者神经肽Y水平、社交功能和认知洞察力：一项病例对照研究

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-26 DOI: 10.1177/10398562261491680

Ibrahim Halil Akbas, Evrim Ozkorumak Karaguzel, Yuksel Aliyazicioglu, Nihal Turkmen Alemdar, Selman Yildirim

{"title":"Neuropeptide Y levels, social functionality, and cognitive insight in patients with schizophrenia in symptomatic remission: A case-control study.","authors":"Ibrahim Halil Akbas, Evrim Ozkorumak Karaguzel, Yuksel Aliyazicioglu, Nihal Turkmen Alemdar, Selman Yildirim","doi":"10.1177/10398562261491680","DOIUrl":"https://doi.org/10.1177/10398562261491680","url":null,"abstract":"ObjectiveThis case-control study aimed to investigate serum neuropeptide Y (NPY) levels in patients with schizophrenia in symptomatic remission and to examine their relationship with social functioning and cognitive insight.MethodsForty patients with schizophrenia in symptomatic remission and 40 healthy controls, matched for age, gender, and educational level, were included. Social functioning was assessed using the Personal and Social Performance (PSP) scale, and cognitive insight was evaluated with the Beck Cognitive Insight Scale (BCIS). Serum NPY levels were measured using enzyme-linked immunosorbent assay (ELISA). Correlation, regression, and receiver operating characteristic (ROC) analyses were performed.ResultsSerum NPY levels were significantly lower in patients with schizophrenia compared to healthy controls (231.4 ± 457.8 ng/L vs 683.0 ± 1097.8 ng/L, p < 0.001). No significant correlations were found between NPY levels and social functioning or cognitive insight. An NPY cut-off value of 125.2 ng/L predicted schizophrenia with 67.5% sensitivity and specificity (AUC = 72.6). Regression analysis demonstrated that clinical insight (PANSS G12 score) was significantly associated with social functioning (β = -11.368, p < 0.05).ConclusionPatients with schizophrenia in symptomatic remission exhibited significantly lower serum NPY levels than healthy controls. However, NPY levels were not associated with social functioning or cognitive insight. These findings suggest that NPY may be a potential biomarker for schizophrenia, although its role in functionality and insight warrants further investigation.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562261491680"},"PeriodicalIF":1.7,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149057275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Trojan horse? The perils of a private health insurers' buying group for clinical independence, patient confidentiality, and the viability of private hospital care. 特洛伊木马?私人健康保险公司的购买群体对临床独立性、患者保密性和私人医院护理可行性的风险。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-26 DOI: 10.1177/10398562261491618

Jeffrey C L Looi, Stephen Allison, Tarun Bastiampillai, Steve Kisely, Luke S-C Woon, Wai-Man Liu

{"title":"Trojan horse? The perils of a private health insurers' buying group for clinical independence, patient confidentiality, and the viability of private hospital care.","authors":"Jeffrey C L Looi, Stephen Allison, Tarun Bastiampillai, Steve Kisely, Luke S-C Woon, Wai-Man Liu","doi":"10.1177/10398562261491618","DOIUrl":"https://doi.org/10.1177/10398562261491618","url":null,"abstract":"Private psychiatric care comprises outpatient as well as private hospital care. The three major funders of private hospital care in Australia are private health insurers, the Australian federal government and, through out-of-pocket costs not covered by the preceding, individual patients. Three big companies, Medibank, BUPA, and nib, dominate the private health insurance market in Australia, resulting in high returns on equity, while private hospitals are being progressively squeezed, resulting in falling profits and a loss in 2024-25. Nonetheless, private health insurers have sought increased collective bargaining power to negotiate fees with private hospitals and care providers, such as psychiatrists, through the formation of buying groups, which would further concentrate the market. In 2021, Honeysuckle Health and nib received authorisation from the Australian Competition and Consumer Commission to act as a buying group for private health insurers with a smaller market share, and other payers. However, a subsequent appeal revealed potential risks to patient and clinician autonomy from buying group contract conditions. In 2026, Honeysuckle Health has applied for an interim and ongoing authorisation from the ACCC to continue as a buying group. We discuss the context and implications of this application for private hospital care, including psychiatry.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562261491618"},"PeriodicalIF":1.7,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149057291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Navigating clozapine discontinuation in clinical practice: An updated framework. 在临床实践中引导氯氮平停药：一个更新的框架。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-25 DOI: 10.1177/10398562261491662

Grace Charter, Nadezda Asceric, Prashant Tibrewal, Tarun Bastiampillai

引用次数: 0

Occurrence of self-harm behaviour and ideation in a prison mental health unit over a 3-year period. 3年期间监狱精神卫生部门出现自残行为和自残意念的情况。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-25 DOI: 10.1177/10398562261491629

Carey Marr, Christie Browne, Mariya Romanovich, Kirsty Smith, Trevor Ma, Vindya Nanayakkara, Sarah-Jane Spencer, Kimberlie Dean

{"title":"Occurrence of self-harm behaviour and ideation in a prison mental health unit over a 3-year period.","authors":"Carey Marr, Christie Browne, Mariya Romanovich, Kirsty Smith, Trevor Ma, Vindya Nanayakkara, Sarah-Jane Spencer, Kimberlie Dean","doi":"10.1177/10398562261491629","DOIUrl":"https://doi.org/10.1177/10398562261491629","url":null,"abstract":"ObjectivePeople in prison have high rates of self-harm and suicide but little is known about the patterns of occurrence over time in custodial settings. Rates of psychiatric diagnoses in custodial settings are also high, and strong associations have been found between psychiatric diagnoses and risk of self-harm and suicidality.MethodsIn this short report, we present a study examining 3 years of data (2020-2023) from a mental health unit within a prison in New South Wales, Australia. We describe the characteristics of the cohort and report rates of self-harm and suicidal behaviours during the admittance.ResultsOverall, 20% of the cohort reported thoughts of self-harm at least once during their stay, and 9% of the cohort had at least one recorded self-harm incident. Multivariable binary logistic regression analyses revealed greater odds of self-harm for individuals with a recorded history of self-harm or suicidal behaviour and for those who reported thoughts of self-harm to staff during their stay.ConclusionsFindings from our study highlight the high rates of self-harm behaviour and ideation among people with mental illness in a custodial setting, supporting the need for targeted prevention and aftercare strategies.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562261491629"},"PeriodicalIF":1.7,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149036419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Bidirectional pathways between incarceration and mental disorders: Implications of Akpanekpo et al. (2026) for adolescent forensic mental health in Indonesia. 监禁与精神障碍之间的双向通路：Akpanekpo等人（2026）对印度尼西亚青少年法医心理健康的影响。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-25 DOI: 10.1177/10398562261491631

Andi Wahyu Irawan, Luluk Humairo Pimada, Dwi Sona

引用次数: 0

Ageism in the RANZCP. RANZCP中的年龄歧视。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-20 DOI: 10.1177/10398562261470231

David Burke

引用次数: 0

Letter to editor: Four patients receive long-term weekly maintenance TMS. 致编辑：4例患者接受长期每周维持性经颅磁刺激。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-20 DOI: 10.1177/10398562261481750

Saxby Pridmore, Gregory M Peterson, Marzena Rybak, Yvonne Turnier-Shea

引用次数: 0

Borderline personality disorder: Challenges in an inpatient setting. 边缘型人格障碍：住院病人的挑战。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-16 DOI: 10.1177/10398562261486316

John Chazhoor, Jarrod Younger

{"title":"Borderline personality disorder: Challenges in an inpatient setting.","authors":"John Chazhoor, Jarrod Younger","doi":"10.1177/10398562261486316","DOIUrl":"https://doi.org/10.1177/10398562261486316","url":null,"abstract":"ObjectiveBorderline Personality Disorder (BPD) remains one of the most challenging conditions encountered in inpatient psychiatry, particularly in regional settings where access to specialised psychological care is limited. Drawing on the personal experience of a public psychiatric specialist practicing in regional Australia, this piece reflects on diagnostic dilemmas, therapeutic boundaries, and the emergence of other challenges unique to the treatment of BPD. A large part of diagnostic complexity in BPD often arises from overlapping symptomatology of differential diagnoses such as Bipolar disorder, Schizoaffective disorder, Depression, complex Post-traumatic stress disorder and other psychiatric conditions, leading to diagnostic ambiguity and a therapeutic drift towards pharmacological over-intervention. Such practices, while well-intentioned, may inadvertently reinforce maladaptive dependency and prolong recovery.ConclusionThere is significant misdiagnosis with conditions that have symptoms that superficially resemble BPD traits. This subsequently leads to the delivery of inappropriate treatments. It is the author's opinion that this is an unintended fallout of the mental healthcare system's risk averse approach. Unfortunately, this leads to a gross deviation from evidence-based treatments for BPD, resulting in poorer outcomes for patients and placing a significant stress on public mental healthcare in Australia.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562261486316"},"PeriodicalIF":1.7,"publicationDate":"2026-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148981984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cobenfy (xanomeline-trospium chloride) for schizophrenia: A clinical update. Cobenfy （xanomeline-trospium chloride）治疗精神分裂症：临床最新进展。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-15 DOI: 10.1177/10398562261486319

Aaron Coates

引用次数: 0